Viewing Study NCT07087002


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-05-19 @ 8:35 AM
Study NCT ID: NCT07087002
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2025-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Sponsor: Stanford University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Medulloblastoma View
None Central Nervous System Embryonal Tumor View
None Refractory Medulloblastoma View
None Recurrent Medulloblastoma View
None Pediatric Brain Tumor View
None Embryonal Tumor With Multilayered Rosettes (ETMR) View
None Pineoblastoma View
None Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS View
None CNS Neuroblastoma View
None FOXR2-activated View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GPC2-CAR T cells View
None Chimeric Antigen Receptor T cells View
None Intracerebroventricular CAR T View
None Pediatric CNS tumors View
None Immunotherapy View
None Medulloblastoma View
None Refractory brain tumors View
None T cell therapy View
None Embryonal Tumor with Multilayered Rosettes (ETMR) View
None Pineoblastoma View
None Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS View
None CNS neuroblastoma View
None FOXR2-activated View